港股異動 | 馬鞍山鋼鐵(0323.HK)高開7.26% 中期純利同比增長471.65%
格隆匯8月26日丨馬鞍山鋼鐵股份(0323.HK)高開7.26%,報3.99港元,最新市值307億港元。馬鞍山鋼鐵昨日晚間發公吿稱,2021年上半年實現營業收入568.64億元,同比增長51.92%;歸屬於上市公司股東的淨利潤46.44億元,同比增長471.65%;歸屬於上市公司股東的扣除非經常性損益的淨利潤47.52億元,同比增長739.60%;基本每股收益0.6030元。瑞信曾發研報上調馬鞍山鋼鐵的盈利預測,將2021-23年盈利預測分別調高33.3%、34.1%、30.3%,目標價由3.8港元上調26%至4.8港元,評級由“中性”升至“跑贏大市”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.